These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36482378)

  • 21. Low-vitamin E diet exacerbates calcium oxalate crystal formation via enhanced oxidative stress in rat hyperoxaluric kidney.
    Huang HS; Ma MC; Chen J
    Am J Physiol Renal Physiol; 2009 Jan; 296(1):F34-45. PubMed ID: 18799548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimethylamine N-oxide promotes hyperoxaluria-induced calcium oxalate deposition and kidney injury by activating autophagy.
    Dong F; Jiang S; Tang C; Wang X; Ren X; Wei Q; Tian J; Hu W; Guo J; Fu X; Liu L; Patzak A; Persson PB; Gao F; Lai EY; Zhao L
    Free Radic Biol Med; 2022 Feb; 179():288-300. PubMed ID: 34767921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress and endoplasmic stress in calcium oxalate stone disease: the chicken or the egg?
    Albert A; Paul E; Rajakumar S; Saso L
    Free Radic Res; 2020 Apr; 54(4):244-253. PubMed ID: 32292073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The advances of calcium oxalate calculi associated drugs and targets.
    Lai Y; Zheng H; Sun X; Lin J; Li Q; Huang H; Hou Y; Zhong H; Zhang D; Fucai T; He Z
    Eur J Pharmacol; 2022 Nov; 935():175324. PubMed ID: 36257382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shape-Specific Nanoceria Mitigate Oxidative Stress-Induced Calcification in Primary Human Valvular Interstitial Cell Culture.
    Xue Y; St Hilaire C; Hortells L; Phillippi JA; Sant V; Sant S
    Cell Mol Bioeng; 2017 Oct; 10(5):483-500. PubMed ID: 30319717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-204 attenuates oxidative stress damage of renal tubular epithelial cells in calcium oxalate kidney-stone formation via MUC4-mediated ERK signaling pathway.
    Xie Z; Chen J; Chen Z
    Urolithiasis; 2022 Feb; 50(1):1-10. PubMed ID: 34783868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of magnesium on calcium oxalate urolithiasis.
    Su CJ; Shevock PN; Khan SR; Hackett RL
    J Urol; 1991 May; 145(5):1092-5. PubMed ID: 2016799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal tubular injury induced by ischemia promotes the formation of calcium oxalate crystals in rats with hyperoxaluria.
    Cao Y; Liu W; Hui L; Zhao J; Yang X; Wang Y; Niu H
    Urolithiasis; 2016 Oct; 44(5):389-97. PubMed ID: 27040948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection.
    Khan SR
    Urol Res; 2005 Nov; 33(5):349-57. PubMed ID: 16292585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxalate at physiological urine concentrations induces oxidative injury in renal epithelial cells: effect of α-tocopherol and ascorbic acid.
    Thamilselvan V; Menon M; Thamilselvan S
    BJU Int; 2014 Jul; 114(1):140-50. PubMed ID: 24460843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of heterologous oxalate decarboxylase in HEK293 cells confers protection against oxalate induced oxidative stress as a therapeutic approach for calcium oxalate stone disease.
    Albert A; Tiwari V; Paul E; Ganesan D; Ayyavu M; Kujur R; Ponnusamy S; Shanmugam K; Saso L; Govindan Sadasivam S
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):426-433. PubMed ID: 28118755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys.
    Umekawa T; Hatanaka Y; Kurita T; Khan SR
    J Am Soc Nephrol; 2004 Mar; 15(3):635-44. PubMed ID: 14978165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursolic acid treats renal tubular epithelial cell damage induced by calcium oxalate monohydrate via inhibiting oxidative stress and inflammation.
    Jia Z; Li W; Bian P; Yang L; Liu H; Pan D; Dou Z
    Bioengineered; 2021 Dec; 12(1):5450-5461. PubMed ID: 34506233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview on recent
    Stephen Inbaraj B; Chen BH
    Asian J Pharm Sci; 2020 Sep; 15(5):558-575. PubMed ID: 33193860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrin-releasing peptide receptor gene silencing inhibits the development of the epithelial-mesenchymal transition and formation of a calcium oxalate crystal in renal tubular epithelial cells in mice with kidney stones via the PI3K/Akt signaling pathway.
    Wang XF; Zhang BH; Lu XQ; Wang RQ
    J Cell Physiol; 2019 Feb; 234(2):1567-1577. PubMed ID: 30144073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citrate provides protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium.
    Byer K; Khan SR
    J Urol; 2005 Feb; 173(2):640-6. PubMed ID: 15643280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.